Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SLAMF7 FPBMC
i
Other names:
SLAMF7 FPBMC, SLAMF7 BATs/CS-1 BATs, anti-CD3 x anti-SLAMF7 bispecific antibody armed activated T cells
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
University of Virginia
Drug class:
CS-1 inhibitor, CD3 inhibitor
Related drugs:
‹
elotuzumab (8)
RXDX-105 (5)
PVX-410 (0)
EGFR bi-armed autologous activated T cells (0)
MGD007 (0)
muromonab-CD3 (0)
VG712 (0)
ertumaxomab (0)
anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells (0)
elotuzumab (8)
RXDX-105 (5)
PVX-410 (0)
EGFR bi-armed autologous activated T cells (0)
MGD007 (0)
muromonab-CD3 (0)
VG712 (0)
ertumaxomab (0)
anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login